Serum ARCHITECT PIVKA-II reference interval in healthy Chinese adults: Sub-analysis from a prospective multicenter study.

Cunling Yan,Jian Hu,Jia Yang,Zhaoyun Chen,Huijun Li,Lianhua Wei,Wei Zhang,Hao Xing,Guoyao Sang,Xiaoqin Wang,Ruilin Han,Ping Liu,Zhihui Li,Zhiyan Li,Ying Huang,Li Jiang,Shunjun Li,Shuyang Dai,Nianyue Wang,Yongfeng Yang,Li Ma,Andrew Soh,Agim Beshiri,Feng Shen,Tian Yang,Zhuping Fan,Yijie Zheng,Wei Chen
DOI: https://doi.org/10.1016/j.clinbiochem.2018.02.007
IF: 3.625
2018-01-01
Clinical Biochemistry
Abstract:•The 95% reference range of PIVKA-II on the Architect analyzer was 13.62–40.38 mAU/ml in Han Chinese subjects.•PIVKA-II level was significantly higher in males than in females (P < 0.001).•This new PIVKA-II reference interval will be more applicable in Chinese adults when tested using the Architect platform.
What problem does this paper attempt to address?